S170. PROGRESSIVE SUBCORTICAL VOLUME LOSS IN TREATMENT-RESISTANT SCHIZOPHRENIA PATIENTS AFTER COMMENCING CLOZAPINE TREATMENT

BACKGROUND: The association of antipsychotic medication with abnormal brain morphometry in schizophrenia remains uncertain. Early studies investigating a switch from first generation antipsychotic to clozapine have steadily shown a decrease of caudate volume over time; however nowadays most patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Schizophr Bull
Autors principals: Tronchin, Giulia, Akudjedu, Theophilus N, Ahmed, Mohamed, Hallahan, Brian, Cannon, Dara M, McDonald, Colm
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Poster Session I
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7234604/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbaa031.236
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars